Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-51.49	24.92	51.38
Graham Fair Price	21.86	1.04	0.86
PEG	126.84	1.17	0.52
Price/Book	27.12	2.66	2.09
Price/Cash Flow	-36.44	33.79	53.16
Prices/Earnings	-36.44	85.91	135.16
Price/Sales	-35.42	0.61	0.94
Price/FCF	-36.44	33.79	53.16
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-33.82	0.05	0.08
Operating Margin	23.98	0.02	0.01
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	0.02	149.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	0.21	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.52	1.44	179.17
EPS QOQ	2.61	0.73	-71.98
FCF QOQ	1.91	1.00	-47.60
Revenue QOQ	0.70	0.97	37.36
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	13.58	6.70	-50.65
Days Sales Outstanding (DSO)	22.49	14.69	-34.67
Inventory Turnover	6.63	13.43	102.62
Debt/Capitalization	0.56	0.56	< 0.005
Quick Ratio	1.12	1.00	-10.44
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2.90	2.50	-13.83
Cash	1.92	1.72	-10.21
Capex	-0.09	-0.16	-72.34
Free Cash Flow	0.11	0.20	72.34
Revenue	6.47	10.97	69.61
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.58	1.23	-22.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.78	4.55	-61.34
Naive Interpretation	Member

06 - Financial Health · Weak

Rating